Want to see TSE:ROMJ full AI Analyst Report?
Rubicon Organics (ROMJ) Stock Price & Analysis
ROMJ Stock Chart & Stats
- Day’s Range
- CAD 0.35 - CAD 0.39
- 52-Week Range
- CAD 0.35 - CAD 0.60
- Previous Close
- CAD 0.36
- Volume
- N/A
- Average Volume (3M)
- 92.80K
- Market Cap
- CAD 24.33M
- Enterprise Value
- CAD 46.33M
- Total Cash (Recent Filing)
- CAD 2.96M
- Total Debt (Recent Filing)
- CAD 15.58M
- Price to Earnings (P/E)
- ―
- Beta
- 0.35
- Next Earnings
- Nov 16, 2026 (Est.)
- EPS Estimate
- 0.02
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Rubicon has scaled revenue substantially over several years, while the latest quarter set a record and maintained strong year-over-year growth. This indicates expanding product demand and distribution, creating a broader base for operating leverage if execution and margins improve.
Premium Brand Position
Leadership in premium flower and recognition for a core brand support customer differentiation in a competitive cannabis market. A stronger branded mix can improve repeat demand, protect product positioning, and provide more opportunity to earn premium margins than undifferentiated wholesale sales.
Yield And Capacity Upside
Higher Pacifica yields and planned capacity expansion could increase available product without requiring proportional increases in fixed infrastructure. If Cascadia is optimized as planned, these improvements may support volume growth, better unit economics, and stronger fulfillment of premium and international demand.
Bears Say
Severe Margin Compression
The sharp decline in gross margin shows that recent revenue growth is not translating into durable profitability. Persistent cost, pricing, or mix pressure could limit operating leverage, weaken reinvestment capacity, and leave the company vulnerable if premium pricing or production improvements take longer than expected.
Negative Cash Generation
Sustained negative operating and free cash flow means the business is not consistently funding operations and investment internally. Continued cash burn can constrain cultivation, automation, and market expansion plans, while increasing reliance on financing or tighter working-capital management over the coming quarters.
Scaling And Liquidity Risk
Cascadia’s delayed yield ramp and elevated growth costs create execution pressure while liquidity is limited. If production efficiency or revenue conversion develops more slowly than planned, higher operating expenses could persist and reduce the financial flexibility available to support the expansion program.
Rubicon Organics News
ROMJ FAQ
What was Rubicon Organics’s price range in the past 12 months?
What is Rubicon Organics’s market cap?
When is Rubicon Organics’s upcoming earnings report date?
How were Rubicon Organics’s earnings last quarter?
Is Rubicon Organics overvalued?
Does Rubicon Organics pay dividends?
What is Rubicon Organics’s EPS estimate?
How many shares outstanding does Rubicon Organics have?
What happened to Rubicon Organics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Rubicon Organics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Rubicon Organics
Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Margaret Ruth Brodie
- Employees
- 265
- Website
- www.rubiconorganics.com
- Address
- 744 West Hastings Street, Vancouver, BC, V6C 1A5, CA
Rubicon Organics (ROMJ) Earnings & Revenues
ROMJ Earnings Call
Earnings Call SentimentPositive
The call communicated clear operational momentum (record revenue, 20% yield gains at Pacifica, Cascadia brought online and certified, market share gains, and margin improvement potential excluding Cascadia start-up costs) alongside typical early-stage scaling challenges (Cascadia yields below targets, modest Q2 Cascadia revenue, higher SG&A, slight YoY decline in adjusted EBITDA, and limited cash). Management offered a coherent plan (yield optimization, in-house extraction, automation, portfolio optimization, international expansion) and expects margin and EBITDA ramp in H2 2026 into 2027. Overall, positives (revenue growth, operational wins, brand strength, certifications) materially outweigh the near-term costs and execution risks.
View all TSE:ROMJ earnings summariesROMJ Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 13 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 1 | 0 | 11 |









